TaimurSherMD

PubMed

• 94 citations
  Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement
  Angela Dispenzieri, Francis K. Buadi, Shaji Kumar, Craig B. Reeder, Tamur Sher
  Mayo Clinic Proceedings. 2015-08-01
• 25 citations
  Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100...
  Abhisek Swaika, Aneel Paulus, Kena C. Miller, Taimur Sher, Nikolaos G. Almyroudis
  The Journal of Supportive Oncology. 2012-07-01
• 102 citations
  Pathophysiology and treatment of cardiac amyloidosis
  Morie A. Gertz, Angela Dispenzieri, Taimur Sher
  Nature Reviews. Cardiology. 2015-02-01

Journal Articles

• Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia Cells  
  Richard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature

Abstracts/Posters

• Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Sociodemographic and Clinical Characteristics Associated with PatientÍs Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers
  Taimur Sher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymph... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018